Related Experiment Video
Updated: Aug 8, 2026
12:57
Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
Prion disease: A loss of antioxidant function?
1Division of Neuropathology, Institute of Pathology, Cleveland, Ohio 44106, USA.
Biochemical and Biophysical Research Communications
|August 31, 2000
Summary
Prion disease may stem from altered antioxidant function due to imbalances in metal-catalyzed reactions. This oxidative stress, linked to cellular prion protein (PrP(C)) changes, may trigger neurodegeneration.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Prion diseases involve the misfolding of cellular prion protein (PrP(C)) into pathogenic forms (PrP(Sc)).
- PrP(C) exhibits copper-binding properties, conferring antioxidant activity primarily through its octarepeats region.
- Truncated PrP forms lacking the octarepeats region are found in human brain tissue, including during prion disease.
Purpose of the Study:
- To investigate the role of metal-catalyzed reactions in prion disease pathogenesis.
- To explore the link between altered antioxidant function of PrP(C) and neurodegeneration.
- To propose a mechanism involving oxidative stress as a trigger for prion disease.
Main Methods:
- Analysis of brain-derived PrP in normal and diseased human brains.
- Assessment of copper-binding and antioxidant properties of PrP.
- Evaluation of metal-catalyzed reactions and oxidative stress markers.
Main Results:
- Evidence suggests imbalances in metal-catalyzed reactions are common in neurodegenerative diseases.
- Altered metal-catalyzed reactions may impair the antioxidant function of PrP(C).
- This impairment can lead to increased oxidative stress, potentially initiating the neurodegenerative process.
Conclusions:
- Imbalances in metal-catalyzed reactions are proposed as a causative factor in prion disease.
- Dysfunctional antioxidant activity of PrP(C) due to metal imbalances contributes to oxidative stress.
- This oxidative stress cascade is implicated in triggering prion disease neurodegeneration.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:27Protein Import into the Peroxisomes
Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...